Charles B Nemeroff is a board certified geriatric psychiatrist who is Director of the University of Miami Center on Aging and Chairman of the Department of Psychiatry and Behavioral Sciences. His research has concentrated on the biological basis of the major neuropsychiatric disorders. His clinical research is focused on the use of genetic, neuroendocrine, neuroimaging and neurochemical methods to comprehensively understand the pathophysiology of depression. In recent years he has uncovered the neurobiological mechanisms that mediate the increased risk for depression in victims of child abuse. He has also contributed to research concerning the relationship of depression to cardiovascular disease, as well as to identifying predictors of specific antidepressant treatment responses.

Dr. Nemeroff has received numerous honors during his career including the distinguished Menninger Prize from the American College of Physicians and the Research Award from the American Foundation for Suicide Prevention. He is a member of the Institute of Medicine of the National Academy of Sciences He has served on the Mental Health Advisory Council of the National Institutes of Mental Health and the Biomedical Research Council for NASA. He is past President of the American College of Neuropsychopharmacology and the American College of Psychiatrists. He is currently a member of the Board of Directors of the American Foundation for Suicide Prevention. He has published more than 900 research reports and reviews.

His research has concentrated on the biological basis of the major neuropsychiatric disorders. His clinical research is focused on the use of genetic, neuroendocrine, neuroimaging and neurochemical methods to comprehensively understand the pathophysiology of depression.

Giampaolo Perna has completed his MD and PhD from Milan State University becoming psychiatrist in the same university. He is the chairman of the department of clinical neurosciences of Hermanas Hospitalarias - Villa San Benedetto Menni near Como Lake. He has published more than 100 papers in impacted journals. He is voluntary professor at Leonard Miller School of Medicine, University of Miami and associate professor at Maastricht University. He is the chair of the WPA section on personalized psychiatry and member of the executive board of the Italian Association for Behavior Analysis and Modification and Cognitive Behavioral Therapy (AIAMC).

Anxiety Disorders, CBT

Jouko Miettunen has university degrees in statistics (MSc 1998; University of Oulu, Finland), epidemiology (MPhil 2003; University of Cambridge, UK), and psychiatry (PhD 2004; University of Oulu, Finland). Since 1997 he has work in various research positions at the University of Oulu, Finland. Currently he holds a position as a Professor in Clinical Epidemiology and he works also as an Academy Research Fellow of the Academy of Finland. He has over 160 peer-reviewed publications in field of psychiatry, his research focus has been especially on Schizophrenia.

Schizophrenia, atopic disorders and depression

Thomas Eduard Schlaepfer, MD is the Vice Chair of Psychiatry and Psychotherapy at the University Hospital Bonn, Germany, where he is also Dean of Medical Education he holds a joint appointment as Associate Professor of Psychiatry and Mental Hygiene at the Johns Hopkins University, Baltimore. He is a fellow of the American College of Neuropsychopharmacology (ACNP) and chair of the Task Force on Brain Stimulation of the World Federation of Societies of Biological Psychiatry. He received his medical training at the University of Bern, Switzerland. He worked as Assistant Professor of the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine, Baltimore, Maryland. Since 1997, he has been Associate Professor of the same department, as well as the Department of Mental Hygiene at the Johns Hopkins University School of Medicine in Baltimore. He focused the research of his group on translational, functional neuroimaging and clinical effects of neuromodulation interventions (including repetitive transcranial magnetic stimulation, vagus nerve stimulation, magnetic seizure therapy and deep brain stimulation) for treatment resistant major depression. After the first human application in the year 2000 his group developed the clinical use of magnetic seizure therapy (MST) for depression and more recently the hypothesis-guided therapeutic use of deep brain stimulation of parts of the human reward system (Nucleus Accumbens and Medial Forebrain Bundle) in the same disorder.

Deep Brain Stimulation

Guillem Feixas Viaplana is currently Professor at the Faculty of Psychology of the University of Barcelona, completed his PhD at this center and holds a Postdoc position at the University of Memphis, USA. He is the Director of the Master in Cognitive Social Therapy and other Postgraduate courses. He has published more than 90 papers in reputed journals and 10 books and led several research projects. His investigations have been focused in interpersonal construing and its role in health (both mental and physical), and in the process of psychotherapy.

Psychotherapy, Self-esteem, Cognitive-behavioral, Cognitive Conflict, Personal Constructs; Repertory Grid, Anxiety Disorders, Eating Disorders, Depression, Family Therapy, Fibromyalgia, Happiness, Hypnosis, Psychotherapy, Cognitive Therapy, Domestic Viole

Ivanka Živčić-Bećirević is a full professor of clinical psychology at Department of Psychology, Faculty of Humanities and Social Sciences, University of Rijeka, Croatia. She is the head of a postgraduate specialist program in psychological counseling, head of the University Counseling Center at University of Rijeka and president of Croatian Association for Behavioral and Cognitive Therapies. She has published 44 scientific and professional papers and 6 book chapters

Jesús Garcia-Martínez completed his PhD at the University of Valencia in 1992. He works at the University of Seville since 1991 and obtained the place of tenured professor in 2002. He’s too accredited therapist and supervisor of the Spanish Association of Cognitive Psychotherapies. His field of research is focused in the treatment of victims and aggressors and in the narratives of change. He have published 15 papers in reputed journals and have presented more than 200 communications in international congress and conferences.

Personality, Evaluation and Psychological Treatment

Rocco de Filippis completed his MD and PhD from Catholic University of the Sacred Heart in Rome. Investigator Meeting (Western Europe and North America) per il BRENDA/Studio di fase II farmacologico sul Nalmefene (LUNDBECK - pharmaceutical company). Barcellona (Spagna) . He holds a Master’s degree and he improved respectively in Bipolar Disorders and Addictive behavior in the years 2011/2012. He currently works and at the Institute of Psychopathology - Rome as a Psychiatrist and Addictive Medicine, and up to now presented as scientific coordinator of CME and Master of Addictive Behaviors; he currently publishes on Bipolar Disorders with high specialization on rapid cycling;he is also an official candidate at the Psychoanalytic Italian Society of the First Italian Center of Rome, and member of IPSO (International Psychoanalytic Studies Organization). He had a oral speech at Translational Medicine 2014 in Las Vegas on QTc Prolungation and PSychotropic Drugs.